UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

The Lancet (British edition), 2016-11, Vol.388 (10057), p.2254-2263

2016

Volltextzugriff (PDF)

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

Diabetes care, 2011-04, Vol.34 (4), p.795-800

2011

Volltextzugriff (PDF)

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

Diabetologia, 2021-07, Vol.64 (7), p.1595-1603

2021

Volltextzugriff (PDF)

CLOuDs Disperse — Top-Notch Glucose Control and Residual C-Peptide Secretion

The New England journal of medicine, 2022-09, Vol.387 (10), p.937-938

Bolinder, Jan

2022

Volltextzugriff (PDF)

C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy

Diabetes care, 2007, Vol.30 (1), p.71-76

2007

Volltextzugriff (PDF)

AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives

Pharmaceutical research, 2007-05, Vol.24 (5), p.1014-1025

2007

Volltextzugriff (PDF)

FreeStyle Libre™ Use for Self-Management of Diabetes in Teenagers and Young Adults

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (4), p.379

2017

Volltextzugriff (PDF)

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

The journal of clinical endocrinology and metabolism, 2012-03, Vol.97 (3), p.1020-1031

2012

Volltextzugriff (PDF)

Clinical use of real-time continuous glucose monitoring

Current diabetes reviews, 2008-08, Vol.4 (3), p.218-222

2008

Volltextzugriff (PDF)

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial

Diabetologia, 2018-03, Vol.61 (3), p.539-550

2018

Volltextzugriff (PDF)

New Insulins, Biosimilars, and Insulin Therapy

Diabetes technology & therapeutics, 2022-03, Vol.24 (S1), p.S35-S-57

2022

Volltextzugriff (PDF)

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Diabetes care, 2021-01, Vol.44 (1), p.141-149

2021

Volltextzugriff (PDF)

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Diabetes technology & therapeutics, 2018-04, Vol.20 (4), p.274-284

2018

Volltextzugriff (PDF)

New Insulins, Biosimilars, and Insulin Therapy

Diabetes technology & therapeutics, 2021-06, Vol.23 (S2), p.S46-S-68

2021

Volltextzugriff (PDF)

Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest

Diabetes (New York, N.Y.), 2002-12, Vol.51 (12), p.3376-3383

2002

Volltextzugriff (PDF)

New Insulins, Biosimilars, and Insulin Therapy

Diabetes technology & therapeutics, 2019-02, Vol.21 (S1), p.S57-S-78

2019

Volltextzugriff (PDF)

New Insulins, Biosimilars, and Insulin Therapy

Diabetes technology & therapeutics, 2020-02, Vol.22 (S1), p.S32-S-46

2020

Volltextzugriff (PDF)

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

Diabetes care, 2006-12, Vol.29 (12), p.2730-2732

2006

Volltextzugriff (PDF)

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Diabetologia, 2024, Vol.67 (8), p.1517-1526

2024

Volltextzugriff (PDF)

The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods

Diabetologia, 2014, Vol.57 (7), p.1375-1381

2014

Volltextzugriff (PDF)

Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors

Acta diabetologica, 2015-06, Vol.52 (3), p.581-589

2015

Volltextzugriff (PDF)

New Insulins, Biosimilars, and Insulin Therapy

Diabetes technology & therapeutics, 2018-02, Vol.20 (S1), p.S55-S-70

2018

Volltextzugriff (PDF)

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.619-630

2021

Volltextzugriff (PDF)

Cutaneous adverse events related to FreeStyle Libre device – Authors' reply

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1396-1397

2017

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

CLOuDs Disperse — Top-Notch Glucose Control and Residual C-Peptide Secretion

C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy

AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives

FreeStyle Libre™ Use for Self-Management of Diabetes in Teenagers and Young Adults

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

Clinical use of real-time continuous glucose monitoring

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial

New Insulins, Biosimilars, and Insulin Therapy

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

New Insulins, Biosimilars, and Insulin Therapy

Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest

New Insulins, Biosimilars, and Insulin Therapy

New Insulins, Biosimilars, and Insulin Therapy

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods

Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors

New Insulins, Biosimilars, and Insulin Therapy

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Cutaneous adverse events related to FreeStyle Libre device – Authors' reply

Suchergebnisse filtern